title: Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.
abstract: The diagnostic performance of a PCR test (Roche Cobas Amplicor CT/NG Test) and that of a ligase chain reaction (LCR) test (Abbott LCx Chlamydia trachomatis assay) were compared by using endocervical and urethral swab specimen culture as a reference test. First-void urine (FVU) and endocervical and urethral swab specimens were collected from 1,015 unselected patients attending a sexually transmitted disease clinic and a clinic for adolescents in Helsinki, Finland. Chlamydia trachomatis was cultured from samples from the endocervix or urethra. PCR was performed with fresh and frozen urine and the culture transport medium. LCR was performed with fresh and frozen urine and LCx swab transport medium. Diagnostic consistency and diagnostic accuracy were statistically tested. The test results were identical for 984 patients (97%). Discrepant results were observed for 31 patients. Overall, LCR and PCR showed excellent kappa coefficients of consistency for both swab and FVU specimens (0.93 and 0.95, respectively). Sixty-one patients (6%) were culture positive. Testing of FVU by LCR or PCR increased the overall positivity rates to 7.0 and 7.7%, respectively. While PCR of FVU detected the greatest number of C. trachomatis infections (sensitivity, 96.1%), for some PCR-positive FVU specimens the results could not be confirmed (specificity, 99.6%). PCR and LCR were more sensitive than culture (sensitivities, 92 and 93% versus 79% for culture) in the diagnosis of genital C. trachomatis infection. In conclusion, both tests can be recommended for use in the clinical laboratory and for the screening of asymptomatic C. trachomatis infections.
authors.affiliation: Haartman Institute, Department of Virology, University of Helsinki, Finland. Mirja.Puolakkainen@Helsinki.fi
authors.forename: M
authors.initials: M
authors.lastname: Puolakkainen
authors.forename: E
authors.initials: E
authors.lastname: Hiltunen-Back
authors.forename: T
authors.initials: T
authors.lastname: Reunala
authors.forename: S
authors.initials: S
authors.lastname: Suhonen
authors.forename: P
authors.initials: P
authors.lastname: Lähteenmäki
authors.forename: M
authors.initials: M
authors.lastname: Lehtinen
authors.forename: J
authors.initials: J
authors.lastname: Paavonen
mesh_terms: D002584:Cervix Uteri / Q000382:microbiology; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000652:urine; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D011088:DNA Ligases / Q000378:metabolism; D005188:False Negative Reactions; D005189:False Positive Reactions; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis* / Q000652:urine; D005615:Freezing; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases; D021141:Nucleic Acid Amplification Techniques; D016133:Polymerase Chain Reaction / Q000379:methods*; D011237:Predictive Value of Tests; D011933:Reagent Kits, Diagnostic; D012680:Sensitivity and Specificity; D014521:Urethra / Q000382:microbiology
chemical_list: D011933:Reagent Kits, Diagnostic; D011088:DNA Ligases